High blood glucose levels brought on by insulin hormone dysregulation characterize the severe condition known as diabetes mellitus. Diabetes is controlled by dietary changes, physical activity, and rigorous blood glucose concentration monitoring. Using a commercially available Non-Invasive Blood Glucose Monitoring Devices to analyze a sample of blood obtained from a finger prick, blood glucose concentration is routinely monitored throughout the day. However, this procedure is intrusive, uncomfortable, and increases the chance of infection. Therefore, noninvasive, affordable, innovative technologies for continuous blood sugar monitoring are urgently needed.
The prototype's accuracy is 79% when using pictures from the finger. The accuracy drops to 62% if it is taken from the ear. These outcomes are reassuring despite the small size of the current data set. Future research on the prototype must, however, address three major issues: (1) expanding the database to increase the robustness of the artificial neural network model; (2) examining the influence of outside variables like skin colour, skin thickness, and ambient temperature in the current prototype; and (3) enhancing the prototype enclosure to make it suitable for straightforward finger and ear placement.
Numerous research teams have been working to create wearable sensors for continuous blood glucose monitoring, but as of this writing, no non-invasive glucose monitors have proven to be commercially effective. The accuracy of a glucose sensor must be more than 15 mg/dl (0.8 mmol/l) in order to produce a sensor system that is usable. Continuous glucose sensor systems may develop in the future to be predictable, picky, trustworthy, and appropriate for patient use.
Non-invasive Blood Glucose Monitoring Devices Market: IntroductionDiabetes is a chronic disease that affects more than 8.5% of the global population.
Monitoring the blood glucose levels (BGLs) on a regular basis is necessary to manage diabetes progression.
Grab an exclusive PDF Brochure of this reportKey Drivers and Restraints of Global Non-invasive Blood Glucose Monitoring Devices MarketDiabetes has evolved as one of the principal health care epidemics of the modern era.
Moreover, obesity is a key risk factor for diabetes.
According to the American Diabetes Association, an estimated 30.3 million people in the U.S. had diabetes in 2015; among these 1.25 million were children.
In January 2020, Integrity Applications, Inc. received CE Mark approval for a major enhancement to GlucoTrack, allowing users to perform the calibration process by themselves, without the need of a certified calibrator.Non-invasive glucose monitoring devices are based on various technologies, which detect characterization of the biological properties of the skin or biological fluids.
